Khiron Life Sciences Corp. is rated 3 out of 5 in the category a global medical cannabis company. Read and write reviews about Khiron Life Sciences Corp.. Khiron Life Sciences Corp. is positioned to be the dominant integrated medical cannabis company in Latin America. Khiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. With a focused regional strategy and patient oriented approach, the company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people. Further information on the company can be accessed through the following link: www.khiron.ca
Address
100 King Street West, Suite 1600, Toronto, Ontario, Canada M5X 1G5. Carrera 15 #88-64
Company size
51-200 employees
Headquarters
Toronto, Ontario